Andrea Lobo,  —

Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.

Articles by Andrea Lobo

Antifungal drug fluconazole reduces cortisol levels in Cushing’s patients

Fluconazole – a treatment for fungal infections – effectively reduced cortisol levels in people with Cushing’s syndrome, without causing significant liver damage, a study in Taiwan showed. According to researchers, these results suggest that fluconazole “may be an effective and safe option for managing” high cortisol levels in people…

Rare nasal tumor causes Cushing’s syndrome in man, 70, in US

The case of a 70-year-old U.S. man with ectopic Cushing’s syndrome caused by an unusual type of nasal tumor, called an olfactory neuroblastoma, was described in a report that, according to its author, “demonstrates the necessity of collaboration among endocrinology, otolaryngology, neurosurgery, radiology, and oncology teams in managing rare ACTH-secreting…

Report warns of Cushing’s risk from prolonged nasal steroid use

A 21-year-old woman in Iran developed Cushing’s syndrome after using a nasal corticosteroid for about a year, according to a recent case study. The report highlights a warning for patients and doctors: even non-oral steroids, like those delivered through the nose, can lead to serious side effects with prolonged use.

Rare ACTH-producing nasal tumor caused ectopic Cushing’s in woman

A rare type of nasal tumor called olfactory neuroblastoma caused ectopic Cushing’s syndrome in a 56-year-old woman, according to a recent case report. The condition was effectively managed with the cortisol-lowering medication metyrapone before being followed by surgery and radiotherapy. After starting metyrapone, the woman developed an opportunistic lung infection,…

Adrenal Cushing’s patients in Japan showing fewer syndrome features

People with adrenal Cushing’s syndrome who were diagnosed in the 2000s often had the condition identified incidentally — but also experience fewer symptoms specific to Cushing’s compared with individuals receiving a diagnosis in previous decades, a study in Japan has found. However, the prevalence of Cushing’s-related complications, including cardiovascular events…

Rare adrenal tumor caused woman’s ectopic Cushing’s syndrome

An adrenocorticotropic hormone (ACTH)-producing pheochromocytoma, a rare type of tumor in the adrenal gland, was the cause of Cushing’s syndrome in a 42-year-old woman, according to a case report in Mexico. The woman had no typical signs of Cushing’s, which delayed her diagnosis and made her “case particularly difficult…

ACTH-producing thymus tumor caused ectopic Cushing’s in woman

A woman in her early 30s who developed severe ectopic Cushing’s syndrome due to a small thymus tumor was effectively managed with medications to reduce cortisol levels followed by surgery, according to a case report from Poland. After the initial surgery, the patient experienced two recurrences of Cushing’s within seven…